IO Biotech, Inc.
SEC CIK 1865494 · IOBT · last insider filing 2025-06-06
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Smith David V | Director | filed 2022 - 2025 |
| Glaub Kathleen Sereda | Director | filed 2021 - 2025 |
| Collins Helen Louise | Director | filed 2023 - 2025 |
| Hirth Peter | Director | filed 2021 - 2025 |
| Elling Christian E | Director | filed 2021 - 2025 |
| Hunter Heidi | Director | filed 2023 - 2025 |
| Zocca Mai-Britt | Director · Chief Executive Officer | filed 2021 - 2025 |
| Lundbeckfond Invest A/S | Director | filed 2021 - 2023 |
| Nielsen Jack | Director | filed 2021 - 2023 |
| Andersson Claus A. | Director | filed 2021 - 2021 |
| Malier Vanessa | Director | filed 2021 - 2021 |
| Belawat Priyanka | Director | filed 2021 - 2021 |
| Coutanceau Emmanuelle | Director | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Smith Devin Whittemore | General Counsel | filed 2023 - 2025 |
| Burkavage Brian | Chief Accounting Officer | filed 2022 - 2025 |
| Sullivan Amy | Chief Financial Officer | filed 2022 - 2025 |
| Ahmad Qasim Iftikhar | Chief Medical Officer | filed 2023 - 2025 |
| Ehrnrooth Eva | Chief Medical Officer | filed 2021 - 2023 |
| Al-Hajj Muhammad | Chief Scientific Officer | filed 2021 - 2023 |
| Vendola Keith A. | Chief Financial Officer | filed 2021 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.